Q2 2025 IOL Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Key Points
- IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) reported a stable total income of INR532 crore for Q2 FY25, showing resilience despite challenging market conditions.
- The company has acquired 11 acres of land for a Greenfield manufacturing facility, indicating plans for future expansion and growth.
- Export revenue from non-Ibuprofen API portfolio increased by 20-25% from the previous quarter, highlighting successful diversification efforts.
- The company has received various regulatory approvals, including from the European market, which could enhance future export opportunities.
- IOL Chemicals And Pharmaceuticals Ltd is focusing on cost efficiency and market strategy improvements to enhance profitability in the long term.
- The EBITDA margin for Q2 FY25 decreased to 9% from 12.9% in the same quarter last year, indicating pressure on profitability.
- Net profit for the quarter dropped significantly to INR19 crore from INR38 crore in the previous year, reflecting financial challenges.
- Employee expenses increased due to variable pay and manpower expansion, impacting overall cost structure.
- The company is facing challenges with subdued API prices and increased competition, particularly in the Ibuprofen segment.
- There is uncertainty regarding the timeline for US FDA inspections and approvals, which could delay market expansion plans.
Ladies and gentlemen, good day. And welcome to the Q2 and H1 FY25 earnings conference call of Il Chemicals and Pharmaceuticals Limited from the management we have with us today, Mr. Pradeep Khanna, Chief Financial Officer, Mr. Abhay Raj Singh, senior VP and company secretary and Mr. Rakesh Mahajan, advisor, finance and strategic. We also have an investor relations team from a factors as a reminder, all participant lines will be in the listen-only more and there will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during the conference call? Please signal an operator by pressing star then zero on your touchtone phone.
Please note that this conference is being recorded. I now hand the conference over to Mr. Darshan Mankad from Adfactors PR for opening your markets. Thank you and over to you, sir.
Good afternoon, everyone. We welcome you to the earnings call of IOL Chemicals and Pharmaceuticals Limited for the second quarter and half year
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
